SamanthaZullowMD

PubMed

• Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease.
  Rachel Porth, Tina Deyhim, Grace Geeganage, Brenden Smith, Samantha Zullow
  Inflammatory Bowel Diseases. 2024-09-26
• 1 citations
  Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States.
  Dallas W Wood, Katherine Treiman, Aileen Rivell, Welmoed K van Deen, Hilary Heyison
  Inflammatory Bowel Diseases. 2024-08-28
• 2 citations
  Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.
  Rachel Porth, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg
  Inflammatory Bowel Diseases. 2024-07-02

Abstracts/Posters

• Histologic Inflammation Defined by the Robarts Histopathologic Index may Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
  George L, Feldman H, Hine AM, Zullow S, Stashek KM, Sun K, Suparna SA. Sarkar, Abutaleb A, Hudesman D, Axelrad JE, Cross RK, Digestive Disease Week 2020, Cancelled due to COVID Pandemic, 5/1/2020
• The Real-World Effectiveness of Ustekinumab in Ulcerative Colitis
  Hong S, Zullow S, Axelrad JE, Chang S, Hudesman D, Crohn's & Colitis Congress, Austin, Texas, 2/1/2020
• Mild Endoscopic Activity Is Associated With an Increased Risk of Relapse in Patients With Ulcerative Colitis
  Feldman, H, George L, Abutaleb A, Hine AM, Zullow S, Axelrad JE, Hudesman D, Cross RK, American College of Gastroenterology, San Antonio, Texas, 10/23/2019
• Effectiveness and Safety of Ustekinumab for Crohn’s Disease in Routine Clinical Practice
  Lynn AM, Barsky M, Ahmed W, Zullow S, Jairath V, Kochhar G, Weiss A, Phipps M, Agrawal M, Click BH, Meserve J, Swaminath A, Bohm M, Sagi S, Fischer M, Chang S, Lawlor..., Digestive Disease Week 2019, San Diego, 5/2019
• Efficacy of Ustekinumab in Patients with Refractory Perianal Crohn’s Disease in a Tertiary Care Population
  Satyam V, Zullow S, Noronha A, Wasan SK, Farraye FA, Digestive Disease Week 2018, Washington DC, 6/2018
• Case Series: Ustekinumab Use in Metastatic Cutaneous Crohn's Disease
  Zullow S, Lichtman MK, Larson A, Stier E, Farraye FA, American College of Gastroenterology, Orlando, FL, 10/2017
• When the Rules Don't Apply: Anticoagulation in Patients with Infective Endocarditis and Embolic Stroke
  Harvey L, Ohm J, Zullow S, Schembri F, Society of General Internal Medicine
• Risk of Gastrointestinal Cancers in Cystic Fibrosis: A Systematic Review and Meta-Analysis
  Zullow S, Sakuraba A, Digestive Disease Week, 5/2015
• A Health Survey of Gastroenterologist Prescribing Practices with Adalimumab for Crohn's Disease
  Zullow S, Greenberg D, Tracy K, Rustgi A, Cross R, Flasar M, Advances in Inflammatory Bowel Diseases, Hollywood, FL, 12/2012
• Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population
  Zullow S, Rustgi A, Quezada S, Cross RK, Digestive Disease Week, 5/2012
• The Role of Histamine 4 Receptor in the Pathogenesis of Crohn's Disease
  Zullow S, Mayer L, SURP Fellows, Mount Sinai, New York, NY, 8/2008
• Join now to see all